- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech High Growth Potential Companies
Hong Kong Pharmaceuticals & Biotech High Growth Potential Companies
Results
30
Companies with a Future performance score of at least 3, ordered by Future performance score.
30 companies
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$113.4b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$486.20
7D
-4.6%
1Y
175.3%
CARsgen Therapeutics Holdings
Market Cap: HK$10.3b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.
2171
HK$18.63
7D
-11.5%
1Y
335.3%
Ascentage Pharma Group International
Market Cap: HK$26.7b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$72.70
7D
-3.4%
1Y
80.8%
RemeGen
Market Cap: HK$61.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$102.00
7D
-1.8%
1Y
559.8%
Akeso
Market Cap: HK$122.2b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$132.70
7D
2.3%
1Y
96.9%
Cutia Therapeutics
Market Cap: HK$3.0b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.73
7D
-7.7%
1Y
-46.1%
WuXi XDC Cayman
Market Cap: HK$91.5b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$74.50
7D
5.8%
1Y
225.3%
Beijing Luzhu Biotechnology
Market Cap: HK$5.0b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.
2480
HK$25.20
7D
1.3%
1Y
5.2%
Ocumension Therapeutics
Market Cap: HK$6.6b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$8.15
7D
-8.0%
1Y
43.7%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$13.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.47
7D
-9.8%
1Y
153.4%
Everest Medicines
Market Cap: HK$19.4b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$54.95
7D
-4.9%
1Y
113.4%
CStone Pharmaceuticals
Market Cap: HK$10.9b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$7.45
7D
-12.4%
1Y
328.2%
InnoCare Pharma
Market Cap: HK$34.4b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$17.55
7D
6.8%
1Y
188.7%
CanSino Biologics
Market Cap: HK$15.8b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$46.96
7D
-9.0%
1Y
94.9%
Nanjing Leads Biolabs
Market Cap: HK$12.5b
A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.
9887
HK$62.90
7D
-1.4%
1Y
n/a
Mirxes Holding
Market Cap: HK$15.2b
A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.
2629
HK$57.85
7D
9.7%
1Y
n/a
Consun Pharmaceutical Group
Market Cap: HK$13.5b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.97
7D
-1.7%
1Y
136.2%
Innovent Biologics
Market Cap: HK$159.7b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$93.25
7D
1.3%
1Y
100.1%
JBM (Healthcare)
Market Cap: HK$2.4b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.93
7D
-5.2%
1Y
208.4%
Luye Pharma Group
Market Cap: HK$13.0b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$3.26
7D
-7.4%
1Y
-1.2%
Frontage Holdings
Market Cap: HK$2.5b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.25
7D
-6.0%
1Y
66.7%
Essex Bio-Technology
Market Cap: HK$2.9b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.17
7D
-1.9%
1Y
111.0%
Simcere Pharmaceutical Group
Market Cap: HK$32.4b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$12.48
7D
-3.0%
1Y
92.3%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$30.60
7D
0%
1Y
n/a
Duality Biotherapeutics
Market Cap: HK$29.6b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$335.80
7D
-15.4%
1Y
n/a
Tong Ren Tang Technologies
Market Cap: HK$6.1b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.79
7D
-2.6%
1Y
-11.1%
WuXi Biologics (Cayman)
Market Cap: HK$158.7b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$39.06
7D
3.4%
1Y
144.4%
Shanghai Haohai Biological Technology
Market Cap: HK$11.6b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$26.00
7D
-2.4%
1Y
-22.3%
Genscript Biotech
Market Cap: HK$34.3b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$15.68
7D
-8.1%
1Y
21.6%
China Medical System Holdings
Market Cap: HK$34.4b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$14.24
7D
-5.2%
1Y
70.5%